CompletedNot Applicable

Uric Acid Levels and Migraine in Children

Turkey (Türkiye)2 participantsStarted 2019-08-01

Plain-language summary

Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to compare serum uric acid levels between pediatric patients with migraine and a control group. Additionally, this study seeks to explore the potential relationship between migraine attack frequency and gender differences in pediatric patients

Who can participate

Age range6 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients diagnosed with migraine Exclusion Criteria: Cerebral palsy Non-migraine headache Epilepsy Multiple congenital anomalies Congenital metabolic diseases Control group Inclusion Criteria: Healthy children Exclusion Criteria Neuromotor developmental delay Multiple congenital anomalies Non-migraine headache Epilepsy

What they're measuring

Evaluation of Uric Acid Levels in Pediatric Patients with Migraine

Timeframe: 01.08.2019 and 01.03.2024

Trial details

NCT IDNCT06966037

SponsorAysen Orman

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Migraine in Children trials